Extension of Approval: A Strategic Advantage
The gematik, the state-controlled approval authority in Germany, has extended the product approval for DocMorris’s CardLink solution until the end of January 2027. This decision allows patients to continue redeeming their e-prescriptions with the electronic health card (eGK) and the DocMorris app.
Market Position and Competitiveness
Thanks to this extension, DocMorris can strengthen its market position and ensure competitiveness. The CardLink solution acts as a bridging technology, creating equal competitive conditions between mail-order pharmacies and local pharmacies.
Transition to PoPP Technology
The extension also supports a smooth transition to PoPP technology (Proof of Patient Presence), which enables contactless use of the eGK without a PIN across Germany. PoPP is expected to increase efficiency in healthcare and simplify the use of e-prescriptions.
Benefits for Investors
For investors, these developments are of great importance as they support the continuation of the e-prescription business and thus the financial stability of DocMorris. This promises a positive future outlook for the company.